You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Exercise Disclosure
Bernstein Harold · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$154.77K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
MAZE daily price context
Close on/before transaction
$25.46
Jun 1, 2026
First close after public filing
$25.4
Jun 4, 2026
30-day return after filing
+27.36%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 14,853 shares @ $10.42
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002050172-26-000023
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$535.88K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Exercise | Jun 1, 2026 | $154.77K |
| Maze Therapeutics, Inc. MAZE | Sale | Jun 1, 2026 | $338.94K |
| Maze Therapeutics, Inc. MAZE | Sale | Jun 1, 2026 | $42.17K |
| Maze Therapeutics, Inc. MAZE | Exercise | Jun 1, 2026 | $0 |